Doctor profile · Federal record
Dr. Kara Foster-Weiss, M,D
Family Medicine Physician (CMS: Family Practice) · Family Nurse Practitioner · North Chesterfield, VA
- NPI 1669426961
- Accepts Medicare
- 15 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
229 Wadsworth Dr
North Chesterfield, VA 232364510
(804) 228-3627
fax (804) 560-1312
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- January 13, 2016
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207Q00000X — NUCC code
- State licenses (2)
- Virginia #0101255880 · Virginia #0017000577
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1669426961. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
131,615
Distinct HCPCS
10
Medicare allowed
$2,772,021
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3111 |
Injection, romosozumab-aqqg, 1 mg | 55,020 | 51 | $10 | |
J1306 |
Injection, inclisiran, 1 mg | 38,340 | 90 | $12 | |
J3380 |
Injection, vedolizumab, 1 mg | 17,400 | 12 | $21 | |
J3245 |
Injection, tildrakizumab, 1 mg | 7,000 | 20 | $138 | |
J0897 |
Injection, denosumab, 1 mg | 6,780 | 74 | $23 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 4,420 | 15 | $33 | |
96372 |
Injection of drug or substance under skin or into muscle | 751 | 252 | $14 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 329 | 129 | $63 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 323 | 135 | $124 | |
J3489 |
Injection, zoledronic acid, 1 mg | 235 | 47 | $8 |
In context: peer comparison
Among 12 peers in this city , average services per provider: 919. This provider delivers 143× the peer median.Open Payments
Industry payments received
All-time total
$548
Transactions
26
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 2 | $148.88 | |
| PFIZER INC. | 4 | $67.56 | |
| Novo Nordisk Inc | 3 | $49.99 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49.09 | |
| AstraZeneca Pharmaceuticals LP | 3 | $41.73 | |
| Amgen Inc. | 2 | $27.89 | |
| Daiichi Sankyo Inc. | 1 | $22.80 | |
| Novartis Pharmaceuticals Corporation | 1 | $21.82 | |
| Exact Sciences Corporation | 1 | $20.80 | |
| Abbott Laboratories | 1 | $19.44 | |
| Boston Scientific Corporation | 1 | $16.87 | |
| Actelion Pharmaceuticals US, Inc. | 1 | $16.48 | |
| Philips North America LLC | 1 | $16.04 | |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15.50 | |
| Seqirus USA Inc | 1 | $13.47 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,085
Patients
393
Total drug cost
$13,039
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 124 | 37 | $1,613 |
| Amlodipine Besylate | Generic | 118 | 37 | $850 |
| Atorvastatin Calcium | Generic | 107 | 36 | $1,332 |
| Rosuvastatin Calcium | Generic | 107 | 36 | $1,313 |
| Lisinopril | Generic | 76 | 21 | $662 |
| Prednisone | Generic | 74 | 60 | $468 |
| Gabapentin | Generic | 65 | 25 | $1,151 |
| Metoprolol Succinate | Generic | 63 | 20 | $1,010 |
| Losartan Potassium | Generic | 59 | 19 | $699 |
| Azithromycin | Generic | 53 | 41 | $293 |
Hospital affiliations
Frequently asked questions
What is Dr. Kara Foster-Weiss's medical specialty?
Dr. Kara Foster-Weiss practices Family Medicine Physician in North Chesterfield, VA.
Where does Dr. Kara Foster-Weiss practice?
Dr. Kara Foster-Weiss practices at 229 Wadsworth Dr, North Chesterfield, VA 232364510. Office phone: 8042283627.
What is Dr. Kara Foster-Weiss's NPI?
Dr. Kara Foster-Weiss's National Provider Identifier (NPI) is 1669426961, issued by NPPES.
Does Dr. Kara Foster-Weiss accept Medicare assignment?
Yes. Dr. Kara Foster-Weiss accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kara Foster-Weiss commonly perform?
Top Medicare-reported procedures in 2023: Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, inclisiran, 1 mg (HCPCS J1306); Injection, vedolizumab, 1 mg (HCPCS J3380). Source: CMS Medicare Physician & Other Practitioners file.